a public good project by the
Synthesis
Company
of California

© 2026

Regulatory T cells in cancer immunotherapy | doi.page

0 citations0 references

Google Scholar doi.org

Regulatory T cells in cancer immunotherapy

Cell Research·2016·Vol. 27(1), pp. 109–118

Citations Over TimeTop 1% of 2016 papers

Atsushi Tanaka, Shimon Sakaguchi

Related Papers

→ Incomplete Depletion and Rapid Regeneration of Foxp3+ Regulatory T Cells Following Anti-CD25 Treatment in Malaria-Infected Mice(2007)150 cited
→ Avian CD4+CD25+ regulatory T cells: Properties and therapeutic applications(2013)42 cited
→ The role of FOXP3 in autoimmunity(2016)32 cited
→ Circulating CD4+CD25−Foxp3+ cells are increased in patients with immune thrombocytopenia(2015)4 cited
[The decreased proportion of CD4+CD25+FOXP3+ regulatory T cells in peripheral blood of children with juvenile idiopathic arthritis and its negative correlation with cytokine level].(2022)